Analysis of KLLN as a high-penetrance breast cancer predisposition gene.

Breast Cancer Research and Treatment
Ella R ThompsonIan G Campbell

Abstract

KLLN is a p53 target gene with DNA binding function and represents a highly plausible candidate breast cancer predisposition gene. We screened for predisposing variants in 860 high-risk breast cancer families using high resolution melt analysis. A germline c.339_340delAG variant predicted to cause premature termination of the protein after 57 alternative amino acid residues was identified in 3/860 families who tested negative for BRCA1 and BRCA2 mutations and in 1/84 sporadic breast cancer cases. However, the variant was also detected in 2/182 families with known BRCA1 or BRCA2 mutations and in 2/464 non-cancer controls. Furthermore, loss of the mutant allele was detected in 2/2 breast tumors. Our data suggest that pathogenic mutations in KLLN are rare in breast cancer families and the c.339_340delAG variant does not represent a high-penetrance breast cancer risk allele.

References

Apr 26, 1985·Science·W K CaveneeB L Gallie
Apr 1, 1971·Proceedings of the National Academy of Sciences of the United States of America·A G Knudson
Jul 2, 1998·British Journal of Cancer·D M EcclesI G Campbell
Feb 22, 2001·Carcinogenesis·S W BaxterI G Campbell
May 5, 2001·Genome Research·P C Ng, S Henikoff
May 10, 2005·Bioinformatics·Carles Ferrer-CostaModesto Orozco
Mar 2, 2006·Breast Cancer Research : BCR·Graham J MannUNKNOWN Kathleen Cuningham Consortium for Research in Familial Breast Cancer
May 29, 2007·Nucleic Acids Research·Yana Bromberg, Burkhard Rost
Apr 4, 2008·Proceedings of the National Academy of Sciences of the United States of America·Yong-Jig Cho, Peng Liang
Oct 28, 2008·Neoplasia : an International Journal for Oncology Research·Kylie L GorringeIan G Campbell
Apr 1, 2010·Nature Methods·Ivan A AdzhubeiShamil R Sunyaev
Aug 3, 2010·Nature Methods·Jana Marie SchwarzDominik Seelow
Oct 29, 2010·Nature·Gonçalo R AbecasisGil A McVean
Dec 24, 2010·JAMA : the Journal of the American Medical Association·Kristi L BennettCharis Eng

❮ Previous
Next ❯

Citations

Mar 1, 2013·Human Molecular Genetics·Emily A NizialekCharis Eng
Jun 7, 2014·Annual Review of Biochemistry·Carolyn A Worby, Jack E Dixon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.